quetiapine fumarate

Generic: quetiapine fumarate

Labeler: accord healthcare inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name quetiapine fumarate
Generic Name quetiapine fumarate
Labeler accord healthcare inc.
Dosage Form TABLET, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

quetiapine fumarate 50 mg/1

Manufacturer
Accord Healthcare Inc.

Identifiers & Regulatory

Product NDC 16729-132
Product ID 16729-132_438fdf1f-3027-fb5a-e063-6294a90ac8d4
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA206252
Listing Expiration 2026-12-31
Marketing Start 2017-11-30

Pharmacologic Class

Classes
atypical antipsychotic [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 16729132
Hyphenated Format 16729-132

Supplemental Identifiers

RxCUI
853201
UPC
0316729132107
UNII
2S3PL1B6UJ

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name quetiapine fumarate (source: ndc)
Generic Name quetiapine fumarate (source: ndc)
Application Number ANDA206252 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 50 mg/1
source: ndc
Packaging
  • 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (16729-132-12)
source: ndc

Packages (1)

Ingredients (1)

quetiapine fumarate (50 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "438fdf1f-3027-fb5a-e063-6294a90ac8d4", "openfda": {"upc": ["0316729132107"], "unii": ["2S3PL1B6UJ"], "rxcui": ["853201"], "spl_set_id": ["72111c36-c625-434f-9f16-7f25e0ff75f3"], "manufacturer_name": ["Accord Healthcare Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (16729-132-12)", "package_ndc": "16729-132-12", "marketing_start_date": "20171130"}], "brand_name": "QUETIAPINE FUMARATE", "product_id": "16729-132_438fdf1f-3027-fb5a-e063-6294a90ac8d4", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Atypical Antipsychotic [EPC]"], "product_ndc": "16729-132", "generic_name": "QUETIAPINE FUMARATE", "labeler_name": "Accord Healthcare Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "QUETIAPINE FUMARATE", "active_ingredients": [{"name": "QUETIAPINE FUMARATE", "strength": "50 mg/1"}], "application_number": "ANDA206252", "marketing_category": "ANDA", "marketing_start_date": "20171130", "listing_expiration_date": "20261231"}